173 related articles for article (PubMed ID: 31651568)
1. Prostate cancer screening in Portugal: prevalence and perception of potential benefits and adverse effects.
Braga R; Costa AR; Pina F; Moura-Ferreira P; Lunet N
Eur J Cancer Prev; 2020 May; 29(3):248-251. PubMed ID: 31651568
[TBL] [Abstract][Full Text] [Related]
2. Screening for prostate cancer.
Ilic D; Neuberger MM; Djulbegovic M; Dahm P
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
[TBL] [Abstract][Full Text] [Related]
3. Occupation as a predictor of prostate cancer screening behaviour in Canada.
Peters CE; Villeneuve PJ; Parent MÉ
J Med Screen; 2020 Dec; 27(4):215-222. PubMed ID: 32000565
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and characteristics of prostate cancer among participants of a community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination.
Ikuerowo SO; Omisanjo OA; Bioku MJ; Ajala MO; Mordi VP; Esho JO
Pan Afr Med J; 2013; 15():129. PubMed ID: 24255735
[TBL] [Abstract][Full Text] [Related]
5. Cancer screening in Portugal: sex differences in prevalence, awareness of organized programmes and perception of benefits and adverse effects.
Costa AR; Silva S; Moura-Ferreira P; Villaverde-Cabral M; Santos O; Carmo ID; Barros H; Lunet N
Health Expect; 2017 Apr; 20(2):211-220. PubMed ID: 26914376
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Outcome of a Single Intervention Population Based Prostate Cancer Screening Study.
Lundgren PO; Kjellman A; Norming U; Gustafsson O
J Urol; 2018 Jul; 200(1):82-88. PubMed ID: 29408619
[TBL] [Abstract][Full Text] [Related]
7. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Pinsky PF; Blacka A; Kramer BS; Miller A; Prorok PC; Berg C
Clin Trials; 2010 Aug; 7(4):303-11. PubMed ID: 20571134
[TBL] [Abstract][Full Text] [Related]
8. The Cuban Institute of Oncology and Radiobiology experience on the beliefs and opinions about digital rectal exam in urological patients.
García Figueredo I; Pereda-Meira CM; Morejón Morales A; Correoso Braña K; Candia MN; Zarut Portillo P; Chappé Pacheco M
Medwave; 2016 Jul; 16(6):e6501. PubMed ID: 27532102
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer screening: what do men know, think and do about their risk? exploring the opinions of men in an urban area in Lagos State, Nigeria: a mixed methods survey.
Ugochukwu UV; Odukoya OO; Ajogwu A; Ojewola RW
Pan Afr Med J; 2019; 34():168. PubMed ID: 32153708
[TBL] [Abstract][Full Text] [Related]
10. Decline in Prostate Cancer Screening by Primary Care Physicians: An Analysis of Trends in the Use of Digital Rectal Examination and Prostate Specific Antigen Testing.
Shoag J; Halpern JA; Lee DJ; Mittal S; Ballman KV; Barbieri CE; Hu JC
J Urol; 2016 Oct; 196(4):1047-52. PubMed ID: 27060052
[TBL] [Abstract][Full Text] [Related]
11. Use of Digital Rectal Examination as an Adjunct to Prostate Specific Antigen in the Detection of Clinically Significant Prostate Cancer.
Halpern JA; Oromendia C; Shoag JE; Mittal S; Cosiano MF; Ballman KV; Vickers AJ; Hu JC
J Urol; 2018 Apr; 199(4):947-953. PubMed ID: 29061540
[TBL] [Abstract][Full Text] [Related]
12. Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study.
Carlsson S; Assel M; Sjoberg D; Ulmert D; Hugosson J; Lilja H; Vickers A
BMJ; 2014 Mar; 348():g2296. PubMed ID: 24682399
[TBL] [Abstract][Full Text] [Related]
13. Why do men refuse or attend population-based screening for prostate cancer?
Nijs HG; Essink-Bot ML; DeKoning HJ; Kirkels WJ; Schröder FH
J Public Health Med; 2000 Sep; 22(3):312-6. PubMed ID: 11077903
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer detection by using digital rectal examination: contemporary practice patterns in the United States.
Tourville EA; Nguyen MM
Clin Genitourin Cancer; 2013 Sep; 11(3):263-9. PubMed ID: 23647941
[TBL] [Abstract][Full Text] [Related]
15. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
[TBL] [Abstract][Full Text] [Related]
16. Baseline PSA testing for men in their 40s: testing in average-risk men aged 40 to 50 years should not be routinely performed.
Carter HB
Oncology (Williston Park); 2014 Feb; 28(2):155-6. PubMed ID: 24701706
[No Abstract] [Full Text] [Related]
17. Why do men refuse prostate cancer screening? Demographic analysis in Turkey.
Ceber E; Cakir D; Ogce F; Simsir A; Cal C; Ozentürk G
Asian Pac J Cancer Prev; 2008; 9(3):387-90. PubMed ID: 18990007
[TBL] [Abstract][Full Text] [Related]
18. A Pragmatic Approach to Prostate Cancer Screening.
Tosoian JJ; Penson DF; Chinnaiyan AM
JAMA; 2024 May; 331(17):1448-1450. PubMed ID: 38581253
[No Abstract] [Full Text] [Related]
19. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
[TBL] [Abstract][Full Text] [Related]
20. Exploring patient perceptions of PSA screening for prostate cancer: risks, effectiveness, and importance.
Smith SD; Birtwhistle R
Can Fam Physician; 2012 Sep; 58(9):e502-7. PubMed ID: 22972741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
